These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 16182218
1. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk. Crook JM, Potters L, Stock RG, Zelefsky MJ. Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218 [Abstract] [Full Text] [Related]
2. Factors predicting an increased dose to the penile bulb in permanent seed prostate brachytherapy. Taussky D, Haider M, McLean M, Yeung I, Williams T, Pearson S, Lockwood G, Crook J. Brachytherapy; 2004; 3(3):125-9. PubMed ID: 15533803 [Abstract] [Full Text] [Related]
3. The effect of the radial function on I-125 seeds used for permanent prostate implantation. Pickett B, Pouliot J. Med Dosim; 2004; 29(3):204-9. PubMed ID: 15324917 [Abstract] [Full Text] [Related]
4. Loose seeds vs. stranded seeds: a comparison of critical organ dosimetry and acute toxicity in (125)I permanent implant for low-risk prostate cancer. Saibishkumar EP, Borg J, Yeung I, Cummins-Holder C, Landon A, Crook JM. Brachytherapy; 2008; 7(2):200-5. PubMed ID: 18362087 [Abstract] [Full Text] [Related]
5. The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. Neill M, Studer G, Le L, McLean M, Yeung I, Pond G, Crook JM. Brachytherapy; 2007; 6(3):173-9. PubMed ID: 17681239 [Abstract] [Full Text] [Related]
6. Dosimetry accuracy as a function of seed localization uncertainty in permanent prostate brachytherapy: increased seed number correlates with less variability in prostate dosimetry. Su Y, Davis BJ, Furutani KM, Herman MG, Robb RA. Phys Med Biol; 2007 Jun 07; 52(11):3105-19. PubMed ID: 17505092 [Abstract] [Full Text] [Related]
7. Factors predicting for urinary incontinence after prostate brachytherapy. McElveen TL, Waterman FM, Kim H, Dicker AP. Int J Radiat Oncol Biol Phys; 2004 Aug 01; 59(5):1395-404. PubMed ID: 15275725 [Abstract] [Full Text] [Related]
8. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98. International Commission on Radiological Protection. Ann ICRP; 2005 Aug 01; 35(3):iii-vi, 3-50. PubMed ID: 16330284 [Abstract] [Full Text] [Related]
9. Favorable toxicity and biochemical control using real-time inverse optimization technique for prostate brachytherapy. Raben A, Rusthoven KE, Sarkar A, Glick A, Benge B, Jacobs D, Raben D. Brachytherapy; 2009 Aug 01; 8(3):297-303. PubMed ID: 19213608 [Abstract] [Full Text] [Related]
10. Clinical and physical determinants for toxicity of 125-I seed prostate brachytherapy. Wust P, von Borczyskowski DW, Henkel T, Rosner C, Graf R, Tilly W, Budach V, Felix R, Kahmann F. Radiother Oncol; 2004 Oct 01; 73(1):39-48. PubMed ID: 15465144 [Abstract] [Full Text] [Related]
11. Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implications. Zelefsky MJ, Yamada Y, Cohen GN, Sharma N, Shippy AM, Fridman D, Zaider M. Radiother Oncol; 2007 Aug 01; 84(2):185-9. PubMed ID: 17692978 [Abstract] [Full Text] [Related]
12. Quality of life of patients after permanent prostate brachytherapy in relation to dosimetry. Van Gellekom MP, Moerland MA, Van Vulpen M, Wijrdeman HK, Battermann JJ. Int J Radiat Oncol Biol Phys; 2005 Nov 01; 63(3):772-80. PubMed ID: 15964707 [Abstract] [Full Text] [Related]
13. Is there a role for postimplant dosimetry after real-time dynamic permanent prostate brachytherapy? Potters L, Calugaru E, Jassal A, Presser J. Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1014-9. PubMed ID: 16682144 [Abstract] [Full Text] [Related]
14. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Wallner K, Roy J, Harrison L. Int J Radiat Oncol Biol Phys; 1995 May 15; 32(2):465-71. PubMed ID: 7751187 [Abstract] [Full Text] [Related]
15. A comparative study of seed localization and dose calculation on pre- and post-implantation ultrasound and CT images for low-dose-rate prostate brachytherapy. Ali I, Algan O, Thompson S, Sindhwani P, Herman T, Cheng CY, Ahmad S. Phys Med Biol; 2009 Sep 21; 54(18):5595-611. PubMed ID: 19717887 [Abstract] [Full Text] [Related]
16. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer. Saibishkumar EP, Borg J, Yeung I, Cummins-Holder C, Landon A, Crook J. Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):61-8. PubMed ID: 18823713 [Abstract] [Full Text] [Related]
17. Virtual HDR CyberKnife treatment for localized prostatic carcinoma: dosimetry comparison with HDR brachytherapy and preliminary clinical observations. Fuller DB, Naitoh J, Lee C, Hardy S, Jin H. Int J Radiat Oncol Biol Phys; 2008 Apr 01; 70(5):1588-97. PubMed ID: 18374232 [Abstract] [Full Text] [Related]
18. CT-ultrasound fusion prostate brachytherapy: a dynamic dosimetry feedback and improvement method. A report of 54 consecutive cases. Fuller DB, Jin H, Koziol JA, Feng AC. Brachytherapy; 2005 Apr 01; 4(3):207-16. PubMed ID: 16182221 [Abstract] [Full Text] [Related]